 | AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc Tue, 24 Jun 2008 4:00pm
|
|
 | AAH - Arana Reports Strong Financial Position - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO Thu, 22 May 2008 3:30pm
|
|
 | AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development Mon, 28 Apr 2008 3:35pm
|
|
 | Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics Wed, 23 Apr 2008 12:15pm
|
|
 | AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer Tue, 18 Mar 2008 3:00pm
|
|
| AAH - Sky TV Update on Phase II Trial Status - Dr John Chiplin, CEO Tue, 18 Mar 2008 12:00pm
|
|
 | AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer Wed, 5 Dec 2007 12:00pm
|
|
 | AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development Fri, 30 Nov 2007 12:40pm
|
|
| AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO Thu, 8 Nov 2007 12:30pm
|
|
 | [PTD] PTD - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO Thu, 9 Aug 2007 3:00pm
|
|
Australia/Sydney
